BlueWind Medical

Neuromodulation Therapy for Urge Urinary Incontinence

Health Tech & Life Sciences
Active
Series B Herzliya Founded 2010
Total raised
$64.0M
Last: Series B 2022-05
Stage
Series B
Founded
2010
Headcount
97
HQ
Herzliya
Sector
Health Tech & Life Sciences

About

BlueWind Medical is an innovative medical device company that aims to transform neuromodulation therapy for urge urinary incontinence (UUI).

The company developed Revi. Its advanced implant design allows for the device to be miniature in size without the need for replacement surgeries for battery change, lead migration, or lead fracture. Its innovative external wearable technology powers the implant for a patient-centric approach to therapy allowing for increases in energy and stimulation sessions based on the patients’ needs, giving patients the flexibility to ensure the best possible outcome.

BlueWind Medical has successfully completed several clinical studies with excellent results and is focused on bringing its implantable tibial neuromodulation system for the treatment of urge urinary incontinence to the market.

BlueWind Medical was founded by the Rainbow Medical Group.

Funding history · 1 round · $64.0M total

2022-05
Series B $64.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B

Highlights

1 PatentsVerified

Tags

neuro-stimulationneurologymedical-devicestherapeutic-devicesmobile-applicationstargeted-therapyminimally-invasivewearablewireless-controlurologytreatmentspersonalizationdigital-healthcarewearable